Abstract:Background The use of Mohs micrographic surgery (MMS) in melanoma treatment has divided opinion and evidence‐based guidelines are lacking. Objectives This systematic review aimed to analyse clinical outcomes for patients with invasive melanomas treated with Mohs rather than wide local excision (WLE). Methods Embase, MEDLINE and Cochrane databases (to 30 August 2023) were searched for studies using Mohs to treat invasive melanoma. Outcomes of interest were local recurrence and death from melanoma. Results Thirty‐five articles involving 41,499 patients with invasive melanoma treated with Mohs were identified. Sixteen studies compared Mohs with WLE and 19 were Mohs‐only, non‐comparative studies. Patients treated with Mohs differed significantly from those undergoing WLE, in particular Mohs patients were older and had thinner melanomas. Two comparative studies using the same data source reported adjusted hazard ratios for melanoma‐specific death and both showed no significant difference between Mohs and WLE‐treated patients; 0.87 (95% CI 0.55–1.35) and 1.20 (95% CI 0.71–20.36). There was also no statistically significant difference in local recurrence risk; the unadjusted risk ratio for patients treated with Mohs was 0.46 (95% CI 0.14–1.51 p = 0.20) with moderate heterogeneity (I2 = 62%). No studies reported multivariable analyses for risk of local recurrence. Many studies generated from relatively few and often overlapping data sets have reported the use of Mohs to treat patients with invasive melanoma. Fewer studies were comparative between Mohs and WLE and these reported substantially different baseline risks of recurrence and death from melanoma between the groups. Mohs has generally been used for thinner melanomas in older patients; therefore, comparisons based on univariable analyses are likely to have been misleading. Conclusions On the basis of currently available data, it is not possible to reliably assess whether outcomes differ if invasive melanomas with comparable features are treated with Mohs or WLE, and randomized trial evidence will be required for reliable conclusions to be reached.

A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma

Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision

Atypical Fibroxanthoma: The Washington University Experience

Time to recurrence after surgical excision of atypical fibroxanthoma-updated systematic review and meta-analysis

Disease-Specific Mortality of Dermatofibrosarcoma Protuberans After Mohs Surgery Versus Wide Local Excision: A Systematic Review and Meta-analysis

Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review

Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil

Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta‐analyses

Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma

Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data

Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.

A review of Mohs micrographic surgery for skin cancer. Part 1: Melanoma and rare skin cancers

micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities

Case Study of Atypical Fibroxanthoma: Presentation and Management

Mohs Micrographic Surgery for Invasive Melanoma Allows for Tissue Preservation Compared With Wide Local Excision: A Retrospective Cohort Study

[Surgical Treatment of Dermatofibrosarcoma Protuberans Using Wide Local Excision Combined with Mohs Micrographic Surgery].

Mohs Micrographic Surgery: A Brief Overview

Autofluorescence Excitation Imaging of Nonmelanoma Skin Cancer for Margin Assessment Before Mohs Micrographic Surgery: A Pilot Study

Cutaneous Atypical Fibroxanthoma With Osteoclast-Like Giant Cell: A Rare but Diagnostic Pitfall

Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review

Percutaneous Microwave Ablation Versus Breast Conserving Surgery for 2-5Cm Breast Cancer: A Two-Center, Retrospective Study